Affinity Asset Advisors key facts
- Affinity Asset Advisors is a hedge fund based in New York, New York with 2 tracked portfolio companies.
- Notable positions include Odyssey Therapeutics, TRexBio.
- Affinity Asset Advisors reports $392.1M in regulatory assets under management across 1 private fund, per its SEC Form ADV (2026-03).
About Affinity Asset Advisors
Founded in 2017
Investment focus
Its SEC Form ADV lists $392 million in regulatory assets under management across 1 private fund (Mar 2026).
Affinity Asset Advisors portfolio at a glance
2 portfolio companies are on record for Affinity Asset Advisors: Odyssey Therapeutics and TRexBio.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Affinity Asset Advisors at the SEC
Form ADV · 2026-03 · CRD 312788- Regulatory AUM
- $392.1M
- Private fund assets
- $1.7B
- Private funds
- 1 · 1 hedge
- Staff
- 10
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as AFFINITY ASSET ADVISORS, LLC).
Free account
See more of the book
- ·Watchlist + alerts for Affinity Asset Advisors's activity
Portfolio
2 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Odyssey Therapeutics | Biotechnology | ▮ | ▮ | ▮ |
| TRexBio | — | ▮ | ▮ | ▮ |
All 2 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Frequently asked about Affinity Asset Advisors
- What companies does Affinity Asset Advisors invest in?
- Affinity Asset Advisors has 2 recorded portfolio companies, including Odyssey Therapeutics, TRexBio.
- What is Affinity Asset Advisors's AUM?
- Affinity Asset Advisors manages approximately $392.1M in assets.